Aptose Biosciences share price today

(APTO)

Aptose Biosciences share price is $0.25 & ₹21.30 as on 25 Dec 2024, 2.30 'hrs' IST

$0.25

Market is closed - opens 8 PM, 26 Dec 2024

View live Aptose Biosciences share price in Dollar and Rupees. Guide to invest in Aptose Biosciences from India. Also see the sentimental analysis on Indian investors investing in Aptose Biosciences. Get details on the Indian mutual funds that are investing in Aptose Biosciences. Get Analyst recommendations and forecasts along with all the Aptose Biosciences's financials.

Aptose Biosciences share price movements

Today's Low: $0.21
Today's High: $0.25
$0.25
14.96%
Downside
Day's Volatility :14.96%
Upside
0.0%
52 Weeks Low: $0.13
52 Weeks High: $2.68
$0.25
48.0%
Downside
52 Weeks Volatility :95.15%
Upside
90.67%

Aptose Biosciences Returns

Period	Aptose Biosciences Inc	Index (Russel 2000)
3 Months	-37.52%	0.0%
6 Months	-66.67%	0.0%
1 Year	-90.23%	0.0%
3 Years	-98.83%	-21.1%

Aptose Biosciences Key Statistics

in dollars & INR

Previous Close	$0.2488
Open	$0.238
Today's High	$0.25
Today's Low	$0.212601
Market Capitalization	$14.8M
Today's Volume	$3.7M
52 Week High	$2.68
52 Week Low	$0.13
Revenue TTM	$0.0
EBITDA	$-36.2M
Earnings Per Share (EPS)	$-2.92
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-694.13%

How to invest in Aptose Biosciences from India?

It is very easy for Indian residents to invest directly in Aptose Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aptose Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aptose Biosciences or APTO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aptose Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aptose Biosciences shares which would translate to 3.408 fractional shares of Aptose Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Aptose Biosciences, in just a few clicks!

Returns in Aptose Biosciences for Indian investors in Rupees

Investment Value

₹1,00,000

Aptose Biosciences investment value today

Current value as on today

₹12,192

Returns

₹87,808

(-87.81%)

Returns from Aptose Biosciences Stock

₹90,234 (-90.23%)

Dollar Returns

₹2,426 (+2.43%)

Indian investors sentiment towards Aptose Biosciences

239.58%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Investment in Aptose Biosciences from India has grown in the last 30 days as on Dec 26, 2024. 239.58% more purchase transactions for Aptose Biosciences in the last 30 days versus the previous period.

327%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Aptose Biosciences on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 327% more investors are searching Aptose Biosciences in the last 30 days versus the previous period.

Global Institutional Holdings in Aptose Biosciences

Armistice Capital, LLC
3.17%
DRW Securities, LLC
1.00%
Sigma Planning Corp
0.68%
UBS Group AG
0.22%
Nantahala Capital Management, LLC
0.13%
Morgan Stanley - Brokerage Accounts
0.05%

Analyst Recommendation on Aptose Biosciences

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Aptose Biosciences(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Aptose Biosciences

What analysts predicted

Upside of 700.0%

Current:

$0.25

Target:

$2.00

Insights on Aptose Biosciences

Price Movement
In the last 7 days, APTO stock has moved up by 39.8%
APTO vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.3% return, outperforming this stock by 116.5%
APTO vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 124.1%

Aptose Biosciences Technicals Summary

Sell

Neutral

Buy

Aptose Biosciences is currently in a neutral trading position according to technical analysis indicators.

Aptose Biosciences Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Aptose Biosciences Inc	35.72%	-66.67%	-90.23%	-98.83%	-99.69%
Regeneron Pharmaceuticals, Inc.	-4.68%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-5.49%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.08%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-11.59%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Aptose Biosciences Inc	NA	NA	0.0	-1.79	-6.94	-1.36	NA	-0.36
Regeneron Pharmaceuticals, Inc.	17.7	17.7	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Aptose Biosciences Inc	Buy	$14.8M	-99.69%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.6B	91.19%	17.7	33.61%
Biontech Se	Buy	$27.2B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.2B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$104.4B	86.41%	32.84	-4.51%

About Aptose Biosciences

aptose biosciences is a science-driven biotechnology company advancing first-in-class agents to treat life-threatening cancers, such as acute myeloid leukemia (aml), high-risk myelodysplastic syndromes (mds) and other hematologic malignancies. based on insights into the genetic and epigenetic profiles of certain cancers and patient populations, aptose is building a pipeline of novel oncology therapies directed at dysregulated processes and signaling pathways. aptose is developing targeted medicines for precision treatment of these diseases, based on a patient’s specific gene expression signature. in the treatment of cancer, this strategy is intended to optimize efficacy and quality of life by minimizing the cytotoxic side effects associated with conventional therapies. cg026806 (cg’806) is a highly potent first-in-class pan-flt3/btk inhibitor. this small molecule therapeutic agent, exhibits a picomolar ic50 toward the fms-like tyrosine kinase 3 with the internal tandem duplication (flt

Organization	Aptose Biosciences
Employees	35
CEO	Dr. William G. Rice Ph.D.
Industry	Health Technology

Management People of Aptose Biosciences

Name	Title
Dr. William G. Rice Ph.D.	Chairman, President & CEO
Mr. Fletcher Payne	Senior VP, CFO, Chief Business Officer & Secretary
Dr. Rafael Bejar M.D., Ph.D.	Senior VP & Chief Medical Officer
Dr. Marc Wiles Ph.D.	Senior Vice President of Regulatory Affairs

Important FAQs about investing in Aptose Biosciences from India :

What is Aptose Biosciences share price today?

Aptose Biosciences share price today stands at $0.25, Open: $0.24 ; Previous Close: $0.25 ; High: $0.25 ; Low: $0.21 ; 52 Week High: $2.68 ; 52 Week Low: $0.13. The stock opens at $0.24, after a previous close of $0.25. The stock reached a daily high of $0.25 and a low of $0.21, with a 52-week high of $2.68 and a 52-week low of $0.13.

Can Indians buy Aptose Biosciences shares?

Yes, Indians can invest in the Aptose Biosciences (APTO) from India.

With INDmoney, you can buy Aptose Biosciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Aptose Biosciences at zero transaction cost.

How can I buy Aptose Biosciences shares from India?

It is very easy to buy Aptose Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aptose Biosciences be purchased?

Yes, you can buy fractional shares of Aptose Biosciences with INDmoney app.

What are the documents required to start investing in Aptose Biosciences stocks?

To start investing in Aptose Biosciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.